Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 2, 2018
Boston Scientific will webcast its conference call with financial results for Q2 ended June 30, 2018. Learn how to tune in.
-
Jun 1, 2018
Key data to be presented at DDW include five-year outcomes after placement of the WallFlex™ RX Fully Covered Stent System RMV.
-
May 16, 2018
Key data will include results for patients treated with LOTUS™ Transcatheter Aortic Valve System and with the Agent™ drug coated balloon.
-
May 14, 2018
Boston Scientific will participate in the upcoming investor conference in May 2018. A live webcast and replay will be available.
-
May 13, 2018Read the facts about our pelvic floor products
The CBS network television show “60 Minutes” recently aired a segment with false claims. Read the facts about Boston Scientific pelvic floor products.
-
May 11, 2018Late-Breaker Data Highlight Reduction in Rate of Inappropriate Shocks with Sensing Filter
Data highlight the successful reduction of inappropriate shocks using the sensing filter in patients implanted with the EMBLEM™ S-ICD System.
-
May 7, 2018
Boston Scientific will participate in the upcoming healthcare conference on May 16, 2018. A live webcast and replay will be available.
-
Apr 30, 2018
Acquisition adds Rezūm®, a therapy for patients with symptomatic benign prostatic hyperplasia (BPH).
-
Apr 25, 2018
"Our consistently strong performance reflects our team's ongoing dedication,” said CEO Mike Mahoney.
-
Apr 24, 2018
Data demonstrated safety and effectiveness of VERCISE™ DBS System for controlling Parkinson’s symptoms.
-
Apr 16, 2018European Patent Office Revokes Edwards Lifesciences '550 Patent
European patent office revokes Edwards Lifesciences '550 patent.
-
Apr 16, 2018Acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer
Boston Scientific acquisition launches women's health focus on cancer and may lead to new diagnostic options for ovarian cancer.
-
Apr 3, 2018Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor
Acquisition strengthens electrophysiology cardiac ablation portfolio with thermal monitor
-
Mar 28, 2018U.K. Court Affirms that Edwards Lifesciences Infringes Boston Scientific Patent
U.K. court affirms that Edwards Lifesciences infringes Boston Scientific patent
-
Mar 26, 2018
Boston Scientific will webcast its conference call with financial results and business highlights for Q1 ended March 31, 2018. Learn how to tune in.
-
Mar 21, 2018Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia
Acquisition expands portfolio with minimally invasive treatment option for patients with benign prostatic hyperplasia
-
Mar 20, 2018
Data demonstrated RHYTHMIA™ Mapping System, paired with the INTELLAMAP ORION™ Mapping Catheter, safe and effective treatment for a variety of arrhythmias
-
Mar 14, 2018
Boston Scientific will participate in the upcoming healthcare conference on March 27, 2018. A live webcast and replay will be available.
-
Mar 12, 2018
Key data presentations at the European Heart Rhythm Association congress to include results for the RHYTHMIA™ Mapping System and the WATCHMAN™ device.
-
Mar 5, 2018
Boston Scientific will participate in the upcoming healthcare conference on March 27, 2018. A live webcast and replay will be available.
-
Mar 5, 2018Acquisition expands endoscopic portfolio to include radiofrequency devices
Acquisition expands endoscopic portfolio to include radiofrequency devices
-
Feb 26, 2018
Boston Scientific announced its completed public offering of senior notes.
-
Feb 22, 2018
Boston Scientific announced the pricing of a public offering of senior notes.
-
Feb 1, 2018
"Our team delivered excellent fourth quarter and full year results, said chairman and CEO Mike Mahoney.
-
Jan 29, 2018
Boston Scientific will participate in the upcoming healthcare conference on Feb. 15, 2018. A live webcast and replay will be available.